References Chapter 3
- Siddiqi K, Lambert M-L, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2005 Mar.21;3(5):288–96.
- Steingart KR, Henry M, Ng V, Hopewell PC. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6:570–81.
- Toman's Tuberculosis: Case Detection Treatment, and Monitoring: Questions and Answers. 2nd ed. Frieden TR, editor. World Health Organization, Geneva; 2004.
- Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, Cunningham J, et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2007May;11(5):485–95.
- Ramsay A, Yassin MA, Cambanis A, Hirao S, Almotawa A, Gammo M, et al. Front-Loading Sputum Microscopy Services: An Opportunity to Optimise Smear-Based Case Detection of Tuberculosis in High Prevalence Countries. J Trop Med. 2009;2009:1–6.
- Laboratory services in tuberculosis control Part II: microscopy. World Health Organization, Geneva. 1998 (WHO/TB/98.258).
http://www.ghdonline.org/drtb/discussion/laboratory-services-in-tuberculosis-controlmicr-2/ - Bonnet M, Ramsay A, Githui W, Gagnidze L, Varaine F, Guerin PJ. Bleach Sedimentation: An Opportunity to Optimize Smear Microscopy for Tuberculosis Diagnosis in Settings of High Prevalence of HIV. Clin Infect Dis. 2008 Jun.;46(11):1710–6.
- Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005 Mar.1;25(3):564–9.
- Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. World Health Organization, Geneva. (WHO/HTM/TB/2008.392).
http://www.who.int/tb/publications/2008/whohtmtb_2008_392/en/index.htm - Rapid implementation of the Xpert MTB/RIF diagnostic test. World Health Organization, Geneva. (WHO/HTM/TB/2011.2).
http://whqlibdoc.who.int/publications/2011/9789241501569_eng.pdf - Prerequisites to country implementation of Xpert MTB/RIF and key action points at country level. World Health Organization, Geneva. (WHO/HTM/TB/2011.12).
http://whqlibdoc.who.int/hq/2011/WHO_HTM_TB_2011.12_eng.pdf - Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. World Health Organization, Geneva. (WHO/HTM/TB/2011.4).
http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf - Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. Elsevier Ltd; 2011 Apr.30;377(9776):1495–505.
- Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis. J Infect. Elsevier Ltd; 2012 Jun.1;64(6):580–8.
http://tbevidence.org/wp-content/uploads/2012/04/Chang-J-Infect-2012.pdf - Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med. 2010 Sep.9; 363(11):1005–15.
http://www.nejm.org/doi/abs/10.1056/NEJMoa0907847 - World Health Organization. The use of Xpert MTB/RIF assay for the detection of pulmonary and extrapulomnary tuberculosis and rifampicin resistance in adults and children. Expert group meeting. October 2013.
http://www.stoptb.org/wg/gli/assets/documents/Xpert%20Meeting%20Report%2024102013%20%20Pre%20publication%20FINAL.pdf - Mironova S, Pimkina E, Kontsevaya I, Nikolayevskyy V, Balabanova Y, Skenders G, Kummik T, Drobniewski F. Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1381-7. Epub 2011 Oct.25.
- Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J Clin Microbiol. 2007 Aug.3;45(8):2635–40.
- Wei-Lun Huang, Ting-Lin Chi, Mei-Hua Wu, Ruwen Jou. Performance Assessment of the GenoType MTBDRsl Test and DNA Sequencing for Detection of Second-Line and Ethambutol Drug Resistance among Patients Infected with Multidrug-Resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011 July; 49(7): 2502–2508. doi: 10.1128/JCM.00197-11.
- Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother. Am Soc Microbiol; 1997 Sep.19;41(10):2093–8.
- Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 7(6):569-574.
- UNTAID Secretariat. Tuberculosis Diagnositc Technology Landscape 2012. UNTAID Secretariat, World Health Organization, Geneva, Switzerland. 2012.
http://www.unitaid.eu/images/marketdynamics/publications/UNITAID-Tuberculosis-Landscape_2012.pdf - Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update. World Health Organization. Geneva, Switzerland 2001 (WHO/HTM/TB/2011.6).
http://whqlibdoc.who.int/publications/2011/9789241501583_eng.pdf - Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care 2006.
http://www.who.int/tb/publications/2006/istc/en/index.html - Tshibwabwa-Tumba E, Mwinga A, Pobee J, Zumla A. Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African Hospitals. Clin Radiol. Elsevier; 2012 Aug.17;52(11):837–41.
- Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: A Radiologic Review. Radiographics. 2007 Sep.1;27(5):1255–73.
- Gryminski J, Krakowka P, Lypacewicz G. The diagnosis of pleural effusion by ultrasonic and radiologic techniques. Chest. 1976.
- Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis. 1993 Dec.;17(6):968–75.
- Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, et al. Predictive value of interferon-[gamma] release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. Elsevier Ltd; 2011 Dec.11; 12(1):45–55.
- Use of tuberculosis interferon-gamma release assays (IGRAs) in low–and middle income countries: policy statement. World Health Organization, Geneva. 2011.
http://whqlibdoc.who.int/publications/2011/9789241502672_eng.pdf - Runyon BA, Montano AA, Akriviadis EA. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Annals of Internal Medicine; 1992. p. 215-20.
- Lawn SD, Kerkhoff AD, Vogt M, Wood R. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):289-94.
- Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker L-G, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS. 2009 Sep.;23(14):1875–80.
- Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Meldau R, Hardy A, Dheda K. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J. 2012 Nov;40(5):1211-20. doi: 10.1183/09031936.00201711. Epub 2012 Feb 23.
- Stephen D Lawn Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infectious Diseases 2012, 12:103. doi:10.1186/1471-2334-12-103.